Amphastar Pharmaceuticals (AMPH) Non Operating Income (2013 - 2026)

Amphastar Pharmaceuticals' Non Operating Income history runs 14 years deep, the most recent figure standing at -$3.6 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 60.16% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at $7.7 million (up 156.78% YoY), while the FY2025 annual figure was $522000.0, down 87.19% from the prior year.
• Non Operating Income was -$3.6 million for Q1 2026 at Amphastar Pharmaceuticals, down from $13.6 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $13.6 million in Q4 2025 to a low of -$27.2 million in Q4 2023.
• Historically, Non Operating Income has averaged -$1.9 million across 5 years, with a median of -$1.5 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Non Operating Income slumped 2177.33% in 2023, then jumped 4253.68% in 2024.
• A 5-year view of Non Operating Income shows it stood at $2.9 million in 2022, then plunged by 1053.38% to -$27.2 million in 2023, then surged by 110.86% to $3.0 million in 2024, then surged by 361.17% to $13.6 million in 2025, then sank by 126.29% to -$3.6 million in 2026.
• The last three Non Operating Income figures came in at -$3.6 million (Q1 2026), $13.6 million (Q4 2025), and -$3.8 million (Q3 2025), per Business Quant data.